OOIR: Observatory of International Research

Papers

(The H4-Index of JAMA Cardiology is 63. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)

Article	Citations
Knowing More Than the Knowns in Familial Hypercholesterolemia	442
Error in Table 1	269
Educational Attainment and Cardiovascular Risk—A Missed Opportunity?	258
Identifying Barriers to Initiation of Sodium-Glucose Cotransporter-2 Inhibitor Therapy in Patients Hospitalized With Heart Failure With Reduced Ejection Fraction—Reply	255
A Patient in His 50s With Chest Tightness and Left Arm and Neck Tingling	226
Primary Prevention Management of Elevated Lipoprotein(a)	215
Anticipating Pharmacological Perturbation With Human Genetic Variation—Lessons From CETP	182
A Woman With Recurrent Torsade de Pointes	179
Implementing Shared Decision-making for Patients With Aortic Stenosis With Longer Life Expectancy	168
The Case for Inclusion of a Lipid Panel in the Standard Precatheterization Laboratory Blood Draw—Stating What Should Be Obvious	168
Ventricular Septal Rupture After ST-Segment Elevation Myocardial Infarction	160
Chest Pain in a Middle-Aged Man	154
Mendelian Randomization and Cardiovascular Disease—Enabling Expert Readership	152
Genome-Wide Association Study of Accessory Atrioventricular Pathways	152
JAMA Cardiology	150
Finding Pulmonary Arterial Hypertension—Switching to Offense to Mitigate Disease Burden	145
Mining the Electronic Medical Record for Hypertension Treatment—Hope or Hype?	142
Lesion-Level Effects of LDL-C–Lowering Therapy in Patients With Acute Myocardial Infarction	137
Association of Longer Leukocyte Telomere Length With Cardiac Size, Function, and Heart Failure	134
Association of Novel Locus With Rheumatic Heart Disease in Black African Individuals	126
Midlife Wealth Mobility and Long-term Cardiovascular Health	126
JAMA Cardiology	118
Accountable Care Organization Participation and Cardiovascular Care Quality	115
USPSTF Report on Aspirin for Primary Prevention	115
Quantifying and Interpreting the Prediction Accuracy of Models for the Time of a Cardiovascular Event—Moving Beyond C Statistic	101

Novel Controlled Metabolic Accelerator for Obesity-Related HFpEF	100
Interventions to Mitigate Risk of Cardiovascular Disease After Adverse Pregnancy Outcomes	100
Culturally Adapted Lifestyle Intervention for South Asian Adults With Cardiovascular Risk Factors	98
Smoking Cessation Improves Outcomes in Patients With Peripheral Artery Disease	97
Spontaneous Coronary Artery Dissection in a Healthy Man With Non–ST Elevation Myocardial Infarction	93
JAMA Cardiology	92
What Is Your Secret to Health?	91
Supraventricular Tachycardia Following Mitral Valve Surgery	89
Influenza Vaccine in High-Risk Cardiovascular Diseases—Define the Target—Reply	89
Assessing Performance of Machine Learning—Reply	88
JAMA Cardiology	86
High-Intensity Interval Training vs Moderate-Intensity Continuous Training for Women Undergoing Cardiovascular Rehabilitation	83
Contribution of Clinical Trial Event Data by Data Source	82
Hypertriglyceridemia in the MESA Study—Reply	82
Critical Appraisal of the Negative Predictive Performance of the European Society of Cardiology 0/1-Hour Algorithm for Evaluating Patients With Chest Pain in the US	81
User Trust in Artificial Intelligence–Guided Lung Ultrasound	80
Race, Racism, and Risk—Implications of Social Determinants of Health in Cardiovascular Disease Prediction	78
Innovation in Event Adjudication—Human vs Machine	78
Beware the Possible Dangers of Chemsex—Is Illicit Drug–Related Sudden Cardiac Death Underestimated?	78
Interpreting Health Status Measures in Patients With Heart Failure—What Counts	78
Transthyretin Cardiac Amyloidosis in the Elderly—Tip of a Heart Failure Iceberg?	77
Peak Oxygen Uptake vs Ventilatory Efficiency	77
A Combined Echocardiography Approach for the Diagnosis of Cancer Therapy–Related Cardiac Dysfunction in Women With Early-Stage Breast Cancer	76
Burden of Rare Genetic Variants in Spontaneous Coronary Artery Dissection With High-risk Features	74
Contemporaneous Comparison of Outcomes Among Patients Implanted With a Leadless vs Transvenous Single-Chamber Ventricular Pacemaker	74
Effect of Transcutaneous Magnetic Stimulation in Patients With Ventricular Tachycardia Storm	74
Aspirin and Hemocompatibility After LVAD Implantation in Patients With Atherosclerotic Vascular Disease	74
Modifiability of Composite Cardiovascular Risk Associated With Chronic Kidney Disease in Type 2 Diabetes With Finerenone	73
Effect of Personalized Accelerated Pacing on Quality of Life, Physical Activity, and Atrial Fibrillation in Patients With Preclinical and Overt Heart Failure With Preserved Ejection Fraction	72
Artificial Intelligence–Guided Lung Ultrasound by Nonexperts	70
Achieving Equitable Access to Acute Myocardial Infarction Therapies for Rural Patients—Is It Possible?	68
Corrected to Open Access Status	66
Change to Open Access Status	66
Time to Treat the Climate and Nature Crisis as One Indivisible Global Health Emergency	66
Professional Preferences and Perceptions of Cardiology Among Internal Medicine Residents	64
PCSK9 in Familial Hypercholesterolemia and Beyond	63
Atherosclerotic Coronary Plaque Regression and Risk of Adverse Cardiovascular Events	63
Potassium Nitrate in Heart Failure With Preserved Ejection Fraction	63